Med device processes
•Download as PPTX, PDF•
0 likes•222 views
The document discusses the medical product realization process and medical device quality system processes. It outlines the steps involved from concept development through design, manufacturing, and post-production activities like monitoring complaints and corrective actions. The overall goal is to design and produce safe and effective medical devices that meet regulatory requirements.
Report
Share
Report
Share
Recommended
Writing for the FDA
The document discusses the Federal Food, Drug, and Cosmetic Act and the role of technical writers in ensuring compliance. It covers how technical writers create user manuals and documentation to support Good Manufacturing Practices for internal and external audiences. It also provides an overview of the multi-tiered documentation system and importance of documentation for standardizing processes, ensuring product quality, and acting as a commitment to the FDA that all processes were followed.
RCM Services
RCM assists life science organizations in achieving regulatory compliance by providing validation services from design through decommissioning using proprietary methodologies and qualified staff. Their services address validation of systems, facilities, equipment, and processes according to FDA requirements and international regulations. They have expertise in a broad range of validation areas including computer systems, laboratory instruments, manufacturing execution systems, and quality management systems. RCM supports clients' compliance needs with services for validation, qualification, implementation, and pharmacovigilance.
Computerized system validation (CSV) as a requirement for good manufacturing ...
The biopharmaceutical industries has more and more used computers to support and accelrate producing of their
products. Computer systems also are accustomed support routine offer of high quality products to boost production
process performance, scale back production prices, and improve product quality. it's vital that these systems square
measure suitable purpose from a business and restrictive perspective. Regulatory authorities treat a lack of regulatory
computer system compliance as a serious GxP deviation.
Industry Implications of Pharmaceutical Quality ICH Guidelines
The document summarizes guidelines from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) related to pharmaceutical quality. It discusses ICH Q8 on pharmaceutical development, Q9 on quality risk management, and Q10 on pharmaceutical quality systems. Q10 describes a comprehensive approach to an effective quality system across a product's lifecycle. It is based on ISO concepts and complements Q8 and Q9. The document reviews the objectives, scope, key elements, and continual improvement aspects of an integrated pharmaceutical quality system as defined in ICH Q10.
Auditing of vendors and production department
This document outlines procedures for auditing vendors that produce capsules and sterile products. It discusses the benefits of vendor audits such as cost savings, process improvements, and risk reduction. The document describes the vendor selection process and provides a checklist for auditing vendors, which includes evaluating their premises, personnel, documentation, validation procedures, samples, stability studies, and drug recall processes. The goal of vendor audits is to inspect vendors' quality management systems and ensure they meet requirements for producing capsules and sterile medical products.
Granulation
This document discusses granulation processes and quality management in the pharmaceutical industry. It covers topics like cGMP, SUPAC guidelines for post-approval changes, validation of granulation equipment and processes, and questionnaires for auditing granulation. The key points are that granulation is a critical manufacturing step that must be validated; SUPAC provides guidance on composition, batch size, site and equipment changes; and validation involves qualifying equipment and demonstrating consistent product quality through processes.
Audit of vendors and Production department
Detailed about the Production Department and Vendor Audit Which is use as in Pharmaceutical Industries.
Accelerating Post-approval Change Management with ICH Q12
Adopting ICH Q12 and modern technologies can reduce the number of changes that require regulatory approval as well as accelerate evaluation, implementation, and global approval of a change. In a 2017 PDA survey, almost 40% of respondents said that 50% or more of their post-approval changes required submission to a health authority. With increasing complexity in the manufacturing of new therapies and growing number of changes that require filing review and updates in multiple markets, the global post-approval change management (PACM) process is becoming unmanageable.
Modern technologies are reducing complexity in pharma by bringing together systems and people to seamlessly support global, end-to-end processes. With greater visibility and collaboration, change management processes are more efficient and less risky. In this webinar, learn:
What is ICH Q12 and potential benefits
Best practices and approaches to key PACM challenges
Approaches to manage ‘established conditions’
How technology can support ICH Q12 and simplify change management
Innovative ways leading pharma companies are addressing PACM
Recommended
Writing for the FDA
The document discusses the Federal Food, Drug, and Cosmetic Act and the role of technical writers in ensuring compliance. It covers how technical writers create user manuals and documentation to support Good Manufacturing Practices for internal and external audiences. It also provides an overview of the multi-tiered documentation system and importance of documentation for standardizing processes, ensuring product quality, and acting as a commitment to the FDA that all processes were followed.
RCM Services
RCM assists life science organizations in achieving regulatory compliance by providing validation services from design through decommissioning using proprietary methodologies and qualified staff. Their services address validation of systems, facilities, equipment, and processes according to FDA requirements and international regulations. They have expertise in a broad range of validation areas including computer systems, laboratory instruments, manufacturing execution systems, and quality management systems. RCM supports clients' compliance needs with services for validation, qualification, implementation, and pharmacovigilance.
Computerized system validation (CSV) as a requirement for good manufacturing ...
The biopharmaceutical industries has more and more used computers to support and accelrate producing of their
products. Computer systems also are accustomed support routine offer of high quality products to boost production
process performance, scale back production prices, and improve product quality. it's vital that these systems square
measure suitable purpose from a business and restrictive perspective. Regulatory authorities treat a lack of regulatory
computer system compliance as a serious GxP deviation.
Industry Implications of Pharmaceutical Quality ICH Guidelines
The document summarizes guidelines from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) related to pharmaceutical quality. It discusses ICH Q8 on pharmaceutical development, Q9 on quality risk management, and Q10 on pharmaceutical quality systems. Q10 describes a comprehensive approach to an effective quality system across a product's lifecycle. It is based on ISO concepts and complements Q8 and Q9. The document reviews the objectives, scope, key elements, and continual improvement aspects of an integrated pharmaceutical quality system as defined in ICH Q10.
Auditing of vendors and production department
This document outlines procedures for auditing vendors that produce capsules and sterile products. It discusses the benefits of vendor audits such as cost savings, process improvements, and risk reduction. The document describes the vendor selection process and provides a checklist for auditing vendors, which includes evaluating their premises, personnel, documentation, validation procedures, samples, stability studies, and drug recall processes. The goal of vendor audits is to inspect vendors' quality management systems and ensure they meet requirements for producing capsules and sterile medical products.
Granulation
This document discusses granulation processes and quality management in the pharmaceutical industry. It covers topics like cGMP, SUPAC guidelines for post-approval changes, validation of granulation equipment and processes, and questionnaires for auditing granulation. The key points are that granulation is a critical manufacturing step that must be validated; SUPAC provides guidance on composition, batch size, site and equipment changes; and validation involves qualifying equipment and demonstrating consistent product quality through processes.
Audit of vendors and Production department
Detailed about the Production Department and Vendor Audit Which is use as in Pharmaceutical Industries.
Accelerating Post-approval Change Management with ICH Q12
Adopting ICH Q12 and modern technologies can reduce the number of changes that require regulatory approval as well as accelerate evaluation, implementation, and global approval of a change. In a 2017 PDA survey, almost 40% of respondents said that 50% or more of their post-approval changes required submission to a health authority. With increasing complexity in the manufacturing of new therapies and growing number of changes that require filing review and updates in multiple markets, the global post-approval change management (PACM) process is becoming unmanageable.
Modern technologies are reducing complexity in pharma by bringing together systems and people to seamlessly support global, end-to-end processes. With greater visibility and collaboration, change management processes are more efficient and less risky. In this webinar, learn:
What is ICH Q12 and potential benefits
Best practices and approaches to key PACM challenges
Approaches to manage ‘established conditions’
How technology can support ICH Q12 and simplify change management
Innovative ways leading pharma companies are addressing PACM
Role of quality systems and audits in pharmaceutical manufacturing environment
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
Short overview of capa
CAPA (Corrective and Preventive Action) processes are required by the FDA and ISO for medical device companies. During audits, regulators evaluate the CAPA process to ensure nonconformances are properly resolved or prevented. The CAPA process involves analyzing quality issues, determining root causes, implementing corrective actions, and verifying the effectiveness of those actions. It is a closed-loop process aimed at continuously improving product quality and compliance.
ISO 9001:2008 Standards Requirements
This document outlines the requirements for an effective quality management system. It specifies that organizations must establish, document, implement and maintain a quality management system to ensure products meet customer and regulatory requirements. Top management is responsible for establishing the quality policy, ensuring adequate resources, reviewing the quality system, and promoting continual improvement. The quality system must include documented procedures and controls for processes like document control, design, purchasing, and customer communication.
White Paper - Application of FDA Current Good Manufacturing Practices
This document discusses FDA regulations for combination drug/device products. It defines combination products as those that are physically combined or co-packaged for use with a specified device. Manufacturers of these products must comply with both drug CGMPs and device quality system regulations. While this may seem daunting, the document recommends augmenting existing drug quality systems to minimize additional requirements. It finds that management review, purchasing controls, corrective action, and design controls are the key areas to address for combination product compliance, with design controls typically requiring the most work to meet all regulations.
Role of computer in clinical development
computers have always played a crucial role in our daily lives, Here i have presented its role in Clinical development.Hope you understand easily from my presentaion.
Tiêu chuẩn GMP WHO trong kiểm nghiệm, đánh giá
Tiêu chuẩn GMP WHO trong kiểm nghiệm, đánh giá. Xem thêm các tài liệu khác trên kênh của Công ty cổ phần Tư vấn Thiết kế GMP EU
Regulation for medical devices
This document discusses regulations for medical devices in various countries and regions. It provides an overview of the regulatory bodies that oversee medical devices in Australia, Europe, the US, Canada, China, Japan, Brazil, and India. For the US, it describes the Food and Drug Administration's role and classifications of medical devices. It also summarizes key concepts around establishing registration and listing of devices, premarket notification (510(k)), de novo classification, premarket approval, and quality system regulations.
Pharmaceutical principles of QA, GMP and QC
This document discusses quality management systems in the pharmaceutical industry. It covers quality assurance, good manufacturing practices, and quality control. Quality assurance aims to ensure medicines are of the required quality for their intended use. Good manufacturing practices ensure consistent production and quality control of medicines. Quality control involves sampling, testing, and releasing products once their quality is verified. Together, quality assurance, good manufacturing practices, and quality control work to deliver safe and effective medicines to patients.
New medical device regulation: implications for medical device manufacturers
Pepgra offers regulatory consulting for Medical device and IVD companies. We help you in Market entry strategy, risk management, device classification and clinical evaluation reports. Let our team of regulatory experts work to ensure your compliance with all national regulations.
Learn More: https://www.pepgra.com/device-manufacturers/
Need Help:
Uk: +44- 7424810299
Email: sales@pepgra.com
Whatsapp: +91 9884350006
Audit
The document discusses different types of audits conducted in the pharmaceutical industry including internal audits, external audits, and regulatory audits. It describes the objectives and processes involved in quality audits. Key points include:
1) Internal audits verify compliance and identify issues before external audits, external audits provide confidence in suppliers, and regulatory audits ensure legal compliance.
2) Audits examine facilities, documentation, practices, and more to evaluate adherence to GMP standards and identify needed improvements.
3) Benefits of audits include assuring GMP compliance, detecting potential problems, improving processes, and increasing management awareness.
Pqs220610.Ppt
This is a presentation based on ICH Q10, Pharmaceutical Quality System, It was shared recently with participants of a training session arranged by Ingrope Information Services karachi at marriot Hotel. I am uploading for the benefits of all pharma colleagues, specially the junior ones.
EU Medical Device Regulation: Preparing for Disruptive (yet Incomplete) Regu...
This document discusses preparing for the upcoming EU Medical Device Regulation (MDR), which aims to improve patient safety but remains incomplete. It outlines an agenda including introductions, a discussion of MDR's likely impact on clinical evidence, transparency, and traceability, and common CEO questions. The discussion covers basic compliance questions companies should consider, mapping a compliance plan over the transition period, and notes that companies should start preparing now rather than waiting for full clarity.
ICH Q 10 guidline
This document presents an overview of the Pharmaceutical Quality Systems (ICH Q10) guideline. ICH Q10 establishes a quality management system model for the pharmaceutical industry and was intended to help companies comply with Good Manufacturing Practices. The objectives of ICH Q10 are to achieve product realization, establish control, and facilitate continual improvement. ICH Q10 also discusses management responsibility, risk management, challenges of implementing the new system, and the relationship between ICH Q10 and other quality standards like GMP.
Freyr UDI Services
On September 24, 2013, the U.S. Food and Drug Administration announced the new requirement to identify medical devices that affect its safe and effective use through the use of UDI. Explore on how Freyr can help medical device companies achieve UDI compliance.
2-ISO 9001-08 REQUIREMENTS-print
This document outlines the requirements of the ISO 9001:2008 quality management system standard. It discusses the eight quality management principles, the structure and requirements of the quality management standard, including management responsibility, resource management, product realization, measurement, analysis and improvement. It provides details on the requirements for the quality management system, documentation, control of documents and records, management review, resource management, and product realization planning.
Quality
This presentation discusses key aspects of quality management in the pharmaceutical industry. It covers the basic elements of quality assurance and quality control. It also discusses various quality approaches like ISO standards and the objectives of quality management. The key principles of quality management are described, including customer focus, leadership, continual improvement, and risk management. Various quality activities are outlined, such as personnel, equipment, sampling, testing, and stability studies. The presentation provides an overview of quality management systems and regulations.
松下幸之助的商品術
The document provides guidelines for quality management systems to improve organizational performance beyond the requirements of ISO 9001. It discusses 8 principles of quality management that should be used by top management to guide the organization. These include customer focus, leadership, involvement of people, a process approach, a systems approach, continual improvement, fact-based decision making, and mutually beneficial supplier relationships. Top management is responsible for establishing systems and processes to understand customer and stakeholder needs and expectations and ensure continual improvement. The quality management system should be documented and its processes defined, managed and improved.
ICH Guidelines
The document discusses the International Conference on Harmonization (ICH). ICH was established in 1990 to harmonize technical requirements for pharmaceutical registration among countries in Europe, Japan and the United States. It aims to ensure safety, quality and efficacy of drugs while avoiding duplication of testing. Key ICH guidelines cover quality, safety, efficacy and multidisciplinary topics. Stability testing guidelines require evaluating drug products under different storage conditions and timepoints to determine shelf life. The harmonization process has led to over 50 guidelines streamlining pharmaceutical research and development globally.
Risk and Quality Management Article
The document discusses the FDA's Pharmaceutical Manufacturing Initiative and its focus on risk-based quality management systems. It summarizes that under the new guidelines, FDA inspections will evaluate facility and equipment systems as well as a manufacturer's product and process understanding and quality control systems. This has significant impacts for pharmaceutical suppliers, including the need to invest in quality management programs, tightly control supply chains, and ensure compliance is passed down to sub-suppliers to maintain approval under the new standards.
How to Start a Med Device Startup From Your Garage - Vancouver Edition
New and improved!
This is a Canada-localized, updated version of my talk on starting a medical device startup with no outside capital.
Given on March 31, 2016 at HxD Vancouver.
2015-CLSA-Report-Recent-Trends-in-FDA-Med-Device-Regulation-Final
The document summarizes recent trends in FDA medical device regulation. It finds that after plateauing in previous years, 510(k) clearance times have recently decreased, suggesting improvements. PMA review times have also improved markedly over the past few years, with the exception of 2013 which saw an increase in panel reviews. While progress has been made, continued efforts are needed to refine review processes and ensure consistent performance across the FDA's divisions.
Healthcare & Med Device - LiveWorx Recommended Agenda
LiveWorx17 Recommended Agenda – May 22-25, 2017 – Boston
LiveWorx is the premier Internet of Things (IoT) Business Event. Learn more-> http://ptc.co/yFPV30barOi
More Related Content
What's hot
Role of quality systems and audits in pharmaceutical manufacturing environment
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
Short overview of capa
CAPA (Corrective and Preventive Action) processes are required by the FDA and ISO for medical device companies. During audits, regulators evaluate the CAPA process to ensure nonconformances are properly resolved or prevented. The CAPA process involves analyzing quality issues, determining root causes, implementing corrective actions, and verifying the effectiveness of those actions. It is a closed-loop process aimed at continuously improving product quality and compliance.
ISO 9001:2008 Standards Requirements
This document outlines the requirements for an effective quality management system. It specifies that organizations must establish, document, implement and maintain a quality management system to ensure products meet customer and regulatory requirements. Top management is responsible for establishing the quality policy, ensuring adequate resources, reviewing the quality system, and promoting continual improvement. The quality system must include documented procedures and controls for processes like document control, design, purchasing, and customer communication.
White Paper - Application of FDA Current Good Manufacturing Practices
This document discusses FDA regulations for combination drug/device products. It defines combination products as those that are physically combined or co-packaged for use with a specified device. Manufacturers of these products must comply with both drug CGMPs and device quality system regulations. While this may seem daunting, the document recommends augmenting existing drug quality systems to minimize additional requirements. It finds that management review, purchasing controls, corrective action, and design controls are the key areas to address for combination product compliance, with design controls typically requiring the most work to meet all regulations.
Role of computer in clinical development
computers have always played a crucial role in our daily lives, Here i have presented its role in Clinical development.Hope you understand easily from my presentaion.
Tiêu chuẩn GMP WHO trong kiểm nghiệm, đánh giá
Tiêu chuẩn GMP WHO trong kiểm nghiệm, đánh giá. Xem thêm các tài liệu khác trên kênh của Công ty cổ phần Tư vấn Thiết kế GMP EU
Regulation for medical devices
This document discusses regulations for medical devices in various countries and regions. It provides an overview of the regulatory bodies that oversee medical devices in Australia, Europe, the US, Canada, China, Japan, Brazil, and India. For the US, it describes the Food and Drug Administration's role and classifications of medical devices. It also summarizes key concepts around establishing registration and listing of devices, premarket notification (510(k)), de novo classification, premarket approval, and quality system regulations.
Pharmaceutical principles of QA, GMP and QC
This document discusses quality management systems in the pharmaceutical industry. It covers quality assurance, good manufacturing practices, and quality control. Quality assurance aims to ensure medicines are of the required quality for their intended use. Good manufacturing practices ensure consistent production and quality control of medicines. Quality control involves sampling, testing, and releasing products once their quality is verified. Together, quality assurance, good manufacturing practices, and quality control work to deliver safe and effective medicines to patients.
New medical device regulation: implications for medical device manufacturers
Pepgra offers regulatory consulting for Medical device and IVD companies. We help you in Market entry strategy, risk management, device classification and clinical evaluation reports. Let our team of regulatory experts work to ensure your compliance with all national regulations.
Learn More: https://www.pepgra.com/device-manufacturers/
Need Help:
Uk: +44- 7424810299
Email: sales@pepgra.com
Whatsapp: +91 9884350006
Audit
The document discusses different types of audits conducted in the pharmaceutical industry including internal audits, external audits, and regulatory audits. It describes the objectives and processes involved in quality audits. Key points include:
1) Internal audits verify compliance and identify issues before external audits, external audits provide confidence in suppliers, and regulatory audits ensure legal compliance.
2) Audits examine facilities, documentation, practices, and more to evaluate adherence to GMP standards and identify needed improvements.
3) Benefits of audits include assuring GMP compliance, detecting potential problems, improving processes, and increasing management awareness.
Pqs220610.Ppt
This is a presentation based on ICH Q10, Pharmaceutical Quality System, It was shared recently with participants of a training session arranged by Ingrope Information Services karachi at marriot Hotel. I am uploading for the benefits of all pharma colleagues, specially the junior ones.
EU Medical Device Regulation: Preparing for Disruptive (yet Incomplete) Regu...
This document discusses preparing for the upcoming EU Medical Device Regulation (MDR), which aims to improve patient safety but remains incomplete. It outlines an agenda including introductions, a discussion of MDR's likely impact on clinical evidence, transparency, and traceability, and common CEO questions. The discussion covers basic compliance questions companies should consider, mapping a compliance plan over the transition period, and notes that companies should start preparing now rather than waiting for full clarity.
ICH Q 10 guidline
This document presents an overview of the Pharmaceutical Quality Systems (ICH Q10) guideline. ICH Q10 establishes a quality management system model for the pharmaceutical industry and was intended to help companies comply with Good Manufacturing Practices. The objectives of ICH Q10 are to achieve product realization, establish control, and facilitate continual improvement. ICH Q10 also discusses management responsibility, risk management, challenges of implementing the new system, and the relationship between ICH Q10 and other quality standards like GMP.
Freyr UDI Services
On September 24, 2013, the U.S. Food and Drug Administration announced the new requirement to identify medical devices that affect its safe and effective use through the use of UDI. Explore on how Freyr can help medical device companies achieve UDI compliance.
2-ISO 9001-08 REQUIREMENTS-print
This document outlines the requirements of the ISO 9001:2008 quality management system standard. It discusses the eight quality management principles, the structure and requirements of the quality management standard, including management responsibility, resource management, product realization, measurement, analysis and improvement. It provides details on the requirements for the quality management system, documentation, control of documents and records, management review, resource management, and product realization planning.
Quality
This presentation discusses key aspects of quality management in the pharmaceutical industry. It covers the basic elements of quality assurance and quality control. It also discusses various quality approaches like ISO standards and the objectives of quality management. The key principles of quality management are described, including customer focus, leadership, continual improvement, and risk management. Various quality activities are outlined, such as personnel, equipment, sampling, testing, and stability studies. The presentation provides an overview of quality management systems and regulations.
松下幸之助的商品術
The document provides guidelines for quality management systems to improve organizational performance beyond the requirements of ISO 9001. It discusses 8 principles of quality management that should be used by top management to guide the organization. These include customer focus, leadership, involvement of people, a process approach, a systems approach, continual improvement, fact-based decision making, and mutually beneficial supplier relationships. Top management is responsible for establishing systems and processes to understand customer and stakeholder needs and expectations and ensure continual improvement. The quality management system should be documented and its processes defined, managed and improved.
ICH Guidelines
The document discusses the International Conference on Harmonization (ICH). ICH was established in 1990 to harmonize technical requirements for pharmaceutical registration among countries in Europe, Japan and the United States. It aims to ensure safety, quality and efficacy of drugs while avoiding duplication of testing. Key ICH guidelines cover quality, safety, efficacy and multidisciplinary topics. Stability testing guidelines require evaluating drug products under different storage conditions and timepoints to determine shelf life. The harmonization process has led to over 50 guidelines streamlining pharmaceutical research and development globally.
Risk and Quality Management Article
The document discusses the FDA's Pharmaceutical Manufacturing Initiative and its focus on risk-based quality management systems. It summarizes that under the new guidelines, FDA inspections will evaluate facility and equipment systems as well as a manufacturer's product and process understanding and quality control systems. This has significant impacts for pharmaceutical suppliers, including the need to invest in quality management programs, tightly control supply chains, and ensure compliance is passed down to sub-suppliers to maintain approval under the new standards.
What's hot (19)
Role of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environment
White Paper - Application of FDA Current Good Manufacturing Practices
White Paper - Application of FDA Current Good Manufacturing Practices
New medical device regulation: implications for medical device manufacturers
New medical device regulation: implications for medical device manufacturers
EU Medical Device Regulation: Preparing for Disruptive (yet Incomplete) Regu...
EU Medical Device Regulation: Preparing for Disruptive (yet Incomplete) Regu...
Viewers also liked
How to Start a Med Device Startup From Your Garage - Vancouver Edition
New and improved!
This is a Canada-localized, updated version of my talk on starting a medical device startup with no outside capital.
Given on March 31, 2016 at HxD Vancouver.
2015-CLSA-Report-Recent-Trends-in-FDA-Med-Device-Regulation-Final
The document summarizes recent trends in FDA medical device regulation. It finds that after plateauing in previous years, 510(k) clearance times have recently decreased, suggesting improvements. PMA review times have also improved markedly over the past few years, with the exception of 2013 which saw an increase in panel reviews. While progress has been made, continued efforts are needed to refine review processes and ensure consistent performance across the FDA's divisions.
Healthcare & Med Device - LiveWorx Recommended Agenda
LiveWorx17 Recommended Agenda – May 22-25, 2017 – Boston
LiveWorx is the premier Internet of Things (IoT) Business Event. Learn more-> http://ptc.co/yFPV30barOi
Modern SEO Techniques Part 1:New SEO Methods for Medical Device Marketers
This two-part series on Modern SEO Techniques for Med Device Marketers can be used by any medical device marketer to understand SEO. Part one will cover modern link building and part two will cover user experience as a search engine ranking factor.
Search Engines. We love them when we’re looking for the hottest sushi restaurant in town. But when it comes to getting our business to rank at the top, they can be a pain in the wasabi.
Med Device Vendors Have Big Opportunities in Health IT Software, Services, an...
If you’re in the medical device manufacturing or hardware sales business your revenue growth (CAGR) is under pressure like never before. You’re being asked to do more with less but you’re probably going to find that hard to accomplish because of one or more of the following challenges:
* Longer product development timelines caused by more FDA and other government regulations
* Increased demand by customers to have your devices deliver user experiences that are more like “consumer” devices such as cell phones and tablets
* Lower margins as a reaction to commodity competition (your sensor hardware business will be commoditized faster and faster over time)
* More complex and longer sales cycles because devices are now being approved for sale not by facilities and clinical executives alone but increasingly by CIOs and IT teams
* Increased cost of risk management and compliance caused by connectivity requirements
Any one of these challenges is difficult to meet but these days you’re probably being asked to meet more than one simultaneously. The solutions are not simple but the good news is that medical device manufacturers have many revenue generation opportunities today that can fund the new strategic imperatives you’ll need to put into place to meet the challenges listed above.
This briefing, presented by Netspective CEO Shahid Shah, describes some of the opportunities and how device vendors can take advantage of them.
Life Science Fast Track Faculty and Mentor Directory
PJ Anand is the founder and CEO of Alcyone Lifesciences, with over 20 years of experience in the life science industry. Prior to founding Alcyone, he held executive roles at Arsenal Medical and Spire Biomedical, where he was responsible for business development, strategic partnerships, and establishing business units. PJ has a background in biochemistry and several patent pending inventions.
Promoting Medical Devices Prior to FDA Approval
Most med device companies will agree with Tom Petty: the waiting is the hardest part. The time period from FDA submission to clearance or approval can feel like an eternity. But what can companies do to get hospitals and providers excited about their technology before launch?
View the presentation for more information on how to promote medical devices prior to FDA approval.
Visit us at www.GreyMatterMarketing.com
Venture Capital Term Sheets (April 7, 2009)
This document discusses key aspects of venture capital term sheets, including sources of capital for startups, typical capital structures, angel investors versus venture capitalists, how to approach angels, venture capital requirements, the current venture capital environment, and four key principles of term sheets: valuation, exit strategy, downside protection, and control. It provides examples and explanations of liquidation preferences, anti-dilution provisions, and rights typically granted to investors in term sheets.
Top 10 lies of Venture Capitalists
The document lists the "Top Ten Lies of Venture Capitalists" which include lies about being able to make quick decisions, not liking a company but partners disagreeing, following leads, needing traction to invest, having lots of available funds, investing in teams, predicting market trends, term sheets being standard, opening doors at companies, and enjoying early-stage investing.
Startup Metrics (Ignite Velocity)
Startup Metrics for Pirates / Startup Metrics 101, presented at Ignite / Velocity Conference (June 2008)
SteadyBudget's Seed Funding Pitch Deck
This is the pitch deck we used in the spring of 2015 to pursue seed funding for our pay-per-click optimization platform SteadyBudget.com.
Zenpayroll Pitch Deck Template
The Pitch Deck That Helped A Startup Land $6 Million From The Founders Of Dropbox, Yelp, Box, Yammer, And Gmail
AdPushup Fundraising Deck - First Pitch
This document discusses AdPushup, a solution that helps web publishers optimize ad revenue. It uses A/B testing of different ad placements, sizes, and types to improve click-through rates and revenue per thousand impressions. Since display advertising is growing significantly, AdPushup's approach can help publishers maximize profits from their ad spaces. A case study showed it increasing one publisher's revenue per thousand impressions from $3.82 to $12.10. AdPushup plans to monetize further as it adds more publisher clients and inventory.
How Wealthsimple raised $2M in 2 weeks
How Wealthsimple raised a $2M seed round in 2 weeks. Presentation from the Mobile Learning Lab hosted by Ward Technology Solutions.
AppVirality.com - Investor Pitch Deck
AppVirality - Plug & Play growth hacking toolkit for Mobile apps.
We help app developers implement Uber/Lyft like in-app referrals under 30 minutes. No coding required.
Checkout - http://appvirality.com
500’s Demo Day Batch 16 >> Podozi
Contact: http://500demoday.co
Want MOAR? Subscribe for our newsletter & event updates: http://bit.ly/1IVVcP4
Swipes pitch deck for Beta Pitch 2013 Finals in Berlin
This was our pitch deck for Beta Pitch 2013 Finals in Berlin. http://swipesapp.com
The deck we used to raise $270k for our startup Castle
Castle (entercastle.com) is a Detroit-based real estate startup that lets rental owners put their properties on autopilot. In April 2015, we closed a $270,000 angel round using this deck.
Questions? Comments? I'd love to hear from you. Email me at max@entercastle.com.
The Deck We Used to Raise $1M Seed Round
This document summarizes a platform that allows users to create customized maps of communities and interests. It started with 20,000 unique users and 18,000 monthly alerts. The platform has since received many requests to build maps for different interests around the world. The document outlines the business model, which includes organizing map data and monetizing through advertising, premium listings, and a potential SAAS model. It provides a timeline showing past pilots and plans for future mobile and discovery features. The team is seeking $1M in funding to further develop their self-service platform.
LaunchRock
The document describes Launchrock, a startup that helps other startups and companies acquire users and understand them. Some key points:
- Launchrock has helped over 1,000,000 startups sign up users and 50,000 get in line for product launches. It has over 3,000 customers.
- It provides user management, marketing, social insights and relationship infrastructure tools to help companies acquire and understand users.
- The CEO is Jameson Detweiler and it has received funding from investors like 500 Startups and advisors from companies like Hubspot, KISSmetrics, and HootSuite.
- Launchrock has helped many companies launch successfully, including the Olsen Twins'
Viewers also liked (20)
How to Start a Med Device Startup From Your Garage - Vancouver Edition
How to Start a Med Device Startup From Your Garage - Vancouver Edition
2015-CLSA-Report-Recent-Trends-in-FDA-Med-Device-Regulation-Final
2015-CLSA-Report-Recent-Trends-in-FDA-Med-Device-Regulation-Final
Healthcare & Med Device - LiveWorx Recommended Agenda
Healthcare & Med Device - LiveWorx Recommended Agenda
Modern SEO Techniques Part 1:New SEO Methods for Medical Device Marketers
Modern SEO Techniques Part 1:New SEO Methods for Medical Device Marketers
Med Device Vendors Have Big Opportunities in Health IT Software, Services, an...
Med Device Vendors Have Big Opportunities in Health IT Software, Services, an...
Life Science Fast Track Faculty and Mentor Directory
Life Science Fast Track Faculty and Mentor Directory
Swipes pitch deck for Beta Pitch 2013 Finals in Berlin
Swipes pitch deck for Beta Pitch 2013 Finals in Berlin
The deck we used to raise $270k for our startup Castle
The deck we used to raise $270k for our startup Castle
Med device processes
- 1. Medical Product Realization Process
- 2. Medical Device Quality System Processes